Medication info

Collesnon 20 mg (Simvastatin)

Prescription medicationTabletOralExpired
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
Yellowish oval film-coated tablet with a reddish tint
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 200200201 · Notified 2002.07.09

This product's status changed to Expired on 2024.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. The recommended dose is 5 ~ 40 mg of this drug once daily in the evening. Adjust the dose as appropriate based on the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this drug, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this drug once daily in the evening. This drug should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not feasible. (2) In elderly patients, the maximum reduction in cholesterol levels can be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug must not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This drug is effective when used alone or in combination with a bile acid sequestrant. When this drug is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Drug under Precautions for Use) and fenofibrate), the dose of this drug must not exceed 10 mg daily. (6) Use in patients with renal impairment As this drug is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, treatment should be initiated at 5 mg daily and the patient should be monitored carefully.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or more between dose adjustments.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication helps reduce the risk of mortality from coronary heart disease and non-fatal myocardial infarction and stroke in adult patients at high risk for cardiovascular diseases, including coronary artery disease, diabetes, peripheral vascular diseases, and stroke. It also reduces associated risks with coronary and non-coronary vascular interventions. Moreover, it lowers total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia or mixed dyslipidemia, while increasing HDL cholesterol levels. In patients with homozygous familial hypercholesterolemia, it is used when other therapies are inadequate or alternatives are not possible, and its administration is monitored with regular checks of lipid levels. In children with heterozygous familial hypercholesterolemia who meet specific criteria, it is used as an adjunct to dietary therapy to lower total cholesterol and LDL cholesterol levels. This medication is effectively used to reduce the risk of cardiovascular diseases and improve dyslipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. The recommended dose is 5 ~ 40 mg of this drug once daily in the evening. Adjust the dose as appropriate based on the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this drug, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this drug once daily in the evening. This drug should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not feasible. (2) In elderly patients, the maximum reduction in cholesterol levels can be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug must not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This drug is effective when used alone or in combination with a bile acid sequestrant. When this drug is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Drug under Precautions for Use) and fenofibrate), the dose of this drug must not exceed 10 mg daily. (6) Use in patients with renal impairment As this drug is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, treatment should be initiated at 5 mg daily and the patient should be monitored carefully.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or more between dose adjustments.

Precautions

This medication is primarily used to lower cholesterol levels in the blood to prevent cardiovascular diseases. When taking this medication, there is a risk of muscle-related problems; therefore, if symptoms such as muscle pain or weakness occur, you must inform your doctor immediately. Particularly, there is an increased risk of serious muscle injury such as myopathy or rhabdomyolysis when taken at high doses, so caution is necessary. Patients with hypersensitivity to this medication or those with liver disease, pregnant women or women who may become pregnant, and breastfeeding women should not take this medication. Moreover, the risk of muscle damage may increase when used in combination with certain medications, so if you are taking other medications, you must inform your doctor or pharmacist. Regular liver function tests are necessary for patients with a history of liver disease or suspected liver dysfunction, as this medication can affect liver function. Older adults, patients with impaired renal function, and those with hypothyroidism need to be monitored more closely when taking this medication. Pregnant women should not take this medication, and women planning to become pregnant should consult a doctor before taking it. During breastfeeding, this medication should be avoided, and if necessary, breastfeeding should be discontinued. This medication is only to be used in children aged 10 years and older, particularly patients with familial hypercholesterolemia aged 10-17 years; other children are advised against taking it. Certain food items such as grapefruit juice should be limited during treatment, and in case of overdose, an immediate visit to a healthcare facility is required. To use this medication safely, regular blood tests and adherence to the doctor's instructions are very important.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 87 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes mellitus
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramp
  • arthralgia
  • dysgeusia
  • ocular motility disorder
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • psychiatric disorder
  • anxiety
  • sleep disorder
  • nightmare
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular muscle weakness
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • biliary obstruction jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • anorexia
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • progression of cataracts
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • skin muscle inflammation
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • erythema multiforme
  • limb sensory numbness
  • paresthesia
  • cold sensation
  • muscle weakness
  • thrombocytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Yellowish oval film-coated tablet with a reddish tint

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.